The U.S. Trustee, the bankruptcy arm of the Justice Department, will appoint one or more committees to represent the interests of creditors and stockholders in working with the company to develop a plan of reorganization to get out of debt.
Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH).
Soliris is considered to be the most expensive drug in the world. It costs Â£340,200 (approximately â¬430,000) per year for ongoing treatment in the UK and $500,000 a year in Canada. and US$409,500 a year in the United States (2010).he trials failed. But if it had worked for arthritis, Alexion would likely have had to charge a much a lower price for this use, as would have to compete against drugs that cost a mere $20,000.. Alexion started selling Soliris in 2008 making $295 million in 2007 with its stock price rising to 130% in 2010.